It is well known that inactivation of the product of the breast cancer 1 (BRCA1) gene is linked to susceptibility to early-onset breast and ovarian cancer [1], [2], and inactivating mutations in the gene confer high lifetime risk of cancer. This evidence concerns the gene BRCA1 and cancer.